In the EPIC study and in the Women’s Health Initiative, C-reactive protein (CRP) and other pro-inflammatory cytokines (such as IL1 receptor antagonist) were found to be positively associated with endometrial cancer [21–23]. This evidence concerns the gene CRP and endometrial cancer.